Biotechnology Companies By Shares Outstanding

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Shares Outstanding
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Shares OutstandingEfficiencyMarket RiskExp Return
1HTDS Hard to Treat
5.48 B
 0.00 
 0.00 
 0.00 
2HLN Haleon plc
4.52 B
 0.06 
 1.45 
 0.08 
3ABBV AbbVie Inc
1.77 B
 0.16 
 1.40 
 0.23 
4GILD Gilead Sciences
1.25 B
 0.16 
 1.59 
 0.25 
5ARYC Arrayit
1.13 B
 0.00 
 0.00 
 0.00 
6NWBO Northwest Biotherapeutics
1.05 B
(0.06)
 3.55 
(0.21)
7VPRO Viropro
916.09 M
 0.00 
 0.00 
 0.00 
8CUBT Curative Biotechnology
903.26 M
 0.08 
 14.15 
 1.13 
9IBRX Immunitybio
853.44 M
 0.03 
 6.44 
 0.19 
10SMMT Summit Therapeutics PLC
737.68 M
 0.05 
 5.40 
 0.29 
11ROIV Roivant Sciences
713.55 M
(0.10)
 1.92 
(0.19)
12OPK Opko Health
671.55 M
 0.13 
 2.58 
 0.33 
13GERN Geron
636.9 M
(0.18)
 5.35 
(0.96)
14GMAB Genmab AS
635.5 M
(0.03)
 2.80 
(0.08)
15AMGN Amgen Inc
537.2 M
 0.18 
 1.53 
 0.28 
16AMRN Amarin PLC
414.19 M
 0.03 
 4.94 
 0.16 
17RXRX Recursion Pharmaceuticals
395.07 M
(0.02)
 6.06 
(0.12)
18MRNA Moderna
386.62 M
(0.05)
 5.40 
(0.26)
19LXRX Lexicon Pharmaceuticals
361.49 M
(0.08)
 9.72 
(0.74)
20EVO Evotec SE ADR
355.11 M
(0.14)
 3.02 
(0.43)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY